MM+M’s Stephen Madden sits down with Dr. Maria Rivas, chief medical officer and SVP global patient safety/medical affairs & evidence & value development at EMD Serono, to talk about the drugmaker’s “patient-directed” approach to drug development, which entails inviting a diverse group of patients to co-create on the design of clinical trials and continuously collaborating with them to ensure its treatments have value for a broader set of people.